Formerly Happy Organon Employees Hate SGP and Are All Leaving ASAP! - Global Drug Information Manager bei Merck: Mitarbeiterbewertung

1.0
30. Sept. 2008
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

It is a large company so very anonymous. You can get by here in a Wally-like" way and not be noticed for years if you do a minimum of work.

Kontras

Management elevated by the Peter Principle. They promote good workers who have no management skills rather than hire or create/train managers. Two faced management. They project that they are ethical and give us nothing but ethics/compliance training, yet lie about their clinical trials. They cut or force out good people to increase shareholder value. This is an awful place to work. Everyone who was knowledgeable from Organon has left.

Mehr Bewertungen zu Merck entdecken

5.0
3. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

End of the year shutdown which includes paid time off

Kontras

The con for me at the time was that I had to relocate which wasn’t possible

4.0
2. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Over my tenure, I had the opportunity to work alongside highly talented and mission-driven colleagues dedicated to improving patient outcomes. The organization provided exposure to cross-functional collaboration, leadership development opportunities, and meaningful work supporting healthcare providers, patients, and community stakeholders. I appreciated the company's commitment to innovation, professional growth, and serving patients through scientific advancement.

Kontras

Like many large organizations, priorities and organizational structures evolved over time, which occasionally created uncertainty and changes in responsibilities. Decision-making processes could sometimes be complex due to the size of the organization, and navigating multiple layers of stakeholders occasionally impacted speed and execution.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle